October 6, 2021 – Cambridge Isotope Laboratories, Inc. (CIL) Launches Stable Isotope-Labeled and Unlabeled TCA Cycle Multi-component Mixes
Tewksbury, MA - Cambridge Isotope Laboratories, Inc. (CIL) is pleased to announce the release of our new stable isotope-labeled and unlabeled TCA cycle mixes to aid in the analysis of TCA-associated compounds in metabolic studies. The TCA (tricarboxylic acid) cycle, also known as the Krebs or citric acid cycle, plays an essential role in central carbon and energy metabolism. The study of its intermediates, and its ancillary compounds, has proven pivotal in not only understanding their impact on metabolism but also in profiling their function in oncogenesis, inflammation, and other pathologies.
September 10, 2021 – Otsuka Group of Companies Celebrates 100th Anniversary with New Symbol and Tagline
Otsuka Group Companies (parent company of Cambridge Isotope Laboratories, Inc.) began to celebrate its 100th anniversary on Sept. 1, 2021. Under the umbrella of Otsuka Holdings Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director, CEO: Tatsuo Higuchi), the Otsuka group consists of 194 companies, including Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Factory, Inc., and Taiho Pharmaceutical Co., Ltd. Representing the entire group, Cambridge Isotope Laboratories would like to convey its appreciation for the patronage and support that has facilitated this milestone.
August 31, 2021 – Cambridge Isotope Laboratories, Inc. Is Now Offering Cannabis Standards for MS-based Testing
CIL now offers solutions for testing the quality and safety of cannabis products with the launch of a variety of stable isotope-labeled and native standards of THC, CBD, and other cannabinoids to assist with testing needs.
July 7, 2021 – Cambridge Isotope Laboratories, Inc. Announces the First Commercially Available Quantum-Grade Gas, 12C Methane QG-alpha™, for High-Performance Nitrogen-Vacancy (NV) Center Diamonds
Cambridge Isotope Laboratories, Inc. (CIL), part of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled compounds, is proud to launch the first commercially available 12C-enriched methane-grade gas for quantum applications.
March 29, 2021 – Cambridge Isotope Laboratories, Inc. and Bruker Biospin Announce Strategic Partnership for the Global Distribution of CIL’s NMR Solvents
Cambridge Isotope Laboratories, Inc. is entering a global, strategic partnership with Bruker BioSpin for the distribution of CIL’s NMR solvents.